CD46 is a cellular receptor for group B adenoviruses
- PMID: 14566335
- DOI: 10.1038/nm952
CD46 is a cellular receptor for group B adenoviruses
Abstract
Group B adenoviruses, a subgenus of human Adenoviridae, are associated with a variety of often-fatal illnesses in immunocompromised individuals, including bone marrow transplant recipients and cancer and AIDS patients. Recently, group B adenovirus derivatives have gained interest as attractive gene therapy vectors because they can transduce target tissues, such as hematopoietic stem cells, dendritic cells and malignant tumor cells, that are refractory to infection by commonly used adenoviral vectors. Whereas many adenoviruses infect cells through the coxsackievirus and adenovirus receptor (CAR), group B adenoviruses use an alternate, as-yet-unidentified cellular attachment receptor. Using mass spectrometric analysis of proteins interacting with a group B fiber, we identified human CD46 as a cellular attachment receptor for most group B adenoviruses. We show that ectopic expression of human CD46 rendered nonhuman cells susceptible to infection with group B viruses in vitro and in vivo. In addition, both siRNA-mediated knockdown of CD46 and a soluble form of CD46 blocked infection of human cell lines and primary human cells. The discovery that group B adenoviruses use CD46, a ubiquitously expressed complement regulatory protein, as a cellular attachment receptor elucidates the diverse clinical manifestation of group B virus infections, and bears directly on the application of these vectors for gene therapy.
Similar articles
-
CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.J Virol. 2005 Nov;79(22):14429-36. doi: 10.1128/JVI.79.22.14429-14436.2005. J Virol. 2005. PMID: 16254377 Free PMC article.
-
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.Cancer Res. 2004 Jul 15;64(14):4919-26. doi: 10.1158/0008-5472.CAN-04-0884. Cancer Res. 2004. PMID: 15256464
-
The short consensus repeats 1 and 2, not the cytoplasmic domain, of human CD46 are crucial for infection of subgroup B adenovirus serotype 35.J Control Release. 2006 Jul 20;113(3):271-8. doi: 10.1016/j.jconrel.2006.05.007. Epub 2006 Jun 21. J Control Release. 2006. PMID: 16790289
-
CD46: a complement regulator and pathogen receptor that mediates links between innate and acquired immune function.Tissue Antigens. 2004 Aug;64(2):111-8. doi: 10.1111/j.1399-0039.2004.00277.x. Tissue Antigens. 2004. PMID: 15245366 Review.
-
[New developments and trends in adenovirus research].Orv Hetil. 1997 Oct 26;138(43):2711-24. Orv Hetil. 1997. PMID: 9411341 Review. Hungarian.
Cited by
-
Two types of functionally distinct fiber containing structural protein complexes are produced during infection of adenovirus serotype 5.PLoS One. 2015 Feb 27;10(2):e0117976. doi: 10.1371/journal.pone.0117976. eCollection 2015. PLoS One. 2015. PMID: 25723153 Free PMC article.
-
Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5.Virol J. 2012 Nov 29;9:296. doi: 10.1186/1743-422X-9-296. Virol J. 2012. PMID: 23190872 Free PMC article.
-
Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model.J Virol. 2012 Sep;86(18):10123-37. doi: 10.1128/JVI.01102-12. Epub 2012 Jul 11. J Virol. 2012. PMID: 22787215 Free PMC article.
-
Adenoviral vector-based strategies against infectious disease and cancer.Hum Vaccin Immunother. 2016 Aug 2;12(8):2064-2074. doi: 10.1080/21645515.2016.1165908. Epub 2016 Apr 22. Hum Vaccin Immunother. 2016. PMID: 27105067 Free PMC article. Review.
-
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Viruses. 2010 Jan;2(1):78-106. doi: 10.3390/v2010078. Viruses. 2010. PMID: 20543907 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases